ArticleFrontiers in immunology2023

Elucidating the direct effects of the novel HDAC inhibitor bocodepsin (OKI-179) on T cells to rationally design regimens for combining with immunotherapy.

Nisha Holay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.